Updates as of May 11, 2022:
- To align with the U.S. Food and Drug Administration's newest guidance for who may receive the Johnson & Johnson COVID-19 Vaccine.
Downloadable Fact Sheets in Multiple Languages
There are currently three different COVID-19 vaccines available to the public.
- The Pfizer-BioNTech accine has full FDA approval for people aged 16 and older and emergency use authorization for people aged 5-15.
- (2 doses, 21 days apart and a booster if eligible)
- The Moderna vaccine has full FDA approval for people aged 18 years and older.
- (2 doses, 28 days apart and a booster if eligible)
- The Johnson & Johnson vaccine has emergency use authorization for people aged 18 and older.
- (1 dose and a booster if eligible)
Note: People between the ages of 12 and 39 may consider waiting 8 weeks between the first and
second dose of the mRNA vaccine series (PDF).
COVID-19 Can Cause Severe Illness
COVID-19 is caused by a coronavirus that spreads in the air, especially when an infected person speaks, sneezes or coughs in poorly ventilated areas. COVID-19 can cause severe illness, hospitalization, or death, and emerging studies show the severe impacts of Long COVID.
Vaccination is Recommended for People Aged 5+
The CDC recommends that all individuals aged 5 and older receive the COVID-19 vaccine. It is your choice to get vaccinated. You can choose which vaccine you receive; however, the CDC recommends the Pfizer-BioNTech and Moderna vaccines as preferred options to the Johnson & Johnson vaccine when possible. Your decisions will not change your standard medical care. Based on CDC and FDA guidance, use of the Johnson & Johnson COVID-19 (J&J) vaccine is limited to people aged 18 and older who cannot receive other COVID-19 vaccines due to medical reasons, have limited access to the other vaccines, or who elect to receive the J&J because they would otherwise not receive a COVID-19 vaccine.
COVID-19 Booster Vaccine Recommendations
The Centers for Disease Control and Prevention (CDC) and The Western States Scientific Safety Review Workgroup recommended that specific populations receive COVID-19 Booster doses after completing their initial vaccination series. Learn more about Boosters and who is recommended to receive one by reading our COVID-19 Booster Vaccine Fact Sheet.
Additional Vaccine Doses for People Whose Immune Systems are Compromised
U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization for both mRNA vaccines, Pfizer-BioNTech and Moderna, for immunocompromised individuals. This authorization covers people aged 5 and older receiving treatments associated with moderate to severe immune compromise. This includes individuals who have:
- Been receiving active cancer treatment for tumors or cancers of the blood
- Received an organ transplant and are taking medicine to suppress the immune system
- Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
- Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
People should talk to their healthcare provider about their medical condition and whether getting an additional dose is appropriate for them.
To learn more read the
Questions and Answers for Additional Vaccine Doses for People Whose Immune Systems are Compromised.
If you need help making an appointment or have questions, call (833) 422-4255 or visit the
Vaccinate All 58 webpage (www.vaccinateall58.com).